Clinical Trial Update: Extension Study of Enteric-coated Mycophenolate Sodium With Short-term or no Steroid Use Compared With Enteric-coated Mycophenolate Sodium With Standard Steroid Therapy in de Novo Kidney Recipients [Phase 4]

View source ↗

Summary

This Phase 4 extension study evaluated whether enteric-coated mycophenolate sodium with short-term or no steroid use provides comparable outcomes to standard st…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Transplantation

Drugs mentioned

• Enteric-coated mycophenolate sodium (mycophenolate sodium)
• PREDNISONE (Prednisone)

Snippet

Sponsor: Novartis | Conditions: Renal Transplantation | Phase 4 | Status: COMPLETED